These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6134944)

  • 41. Prenatal diagnosis of Duchenne muscular dystrophy by DNA analysis.
    Old JM; Davies KE
    J Med Genet; 1986 Dec; 23(6):556-9. PubMed ID: 2879927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dystrophin-related muscular dystrophies.
    Witkowski JA
    J Child Neurol; 1989 Oct; 4(4):251-71. PubMed ID: 2571631
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carrier detection in Duchenne muscular dystrophy: Assessment of the effect of age on detection-rate with serum-creatine-kinase-activity.
    Nicholson GA; Gardner-Medwin D; Pennington RJ; Walton JN
    Lancet; 1979 Mar; 1(8118):692-4. PubMed ID: 85935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A case of an 8-year-old girl, a symptomatic carrier of Duchenne's muscular dystrophy].
    Kurihara M; Imai Y; Kumagai K; Hasegawa H; Nonaka M
    No To Hattatsu; 1990 Jul; 22(4):394-6. PubMed ID: 2400617
    [No Abstract]   [Full Text] [Related]  

  • 45. Serum creatine kinase activity and carrier status for duchenne muscular dystrophy.
    Bullock DG; McSweeney FM; Whitehead TP; Edwards JH
    Lancet; 1979 Dec 22-29; 2(8156-8157):1370. PubMed ID: 92710
    [No Abstract]   [Full Text] [Related]  

  • 46. DMD-specific FISH probes are diagnostically useful in the detection of female carriers of DMD gene deletions.
    Voskova-Goldman A; Peier A; Caskey CT; Richards CS; Shaffer LG
    Neurology; 1997 Jun; 48(6):1633-8. PubMed ID: 9191779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular analysis and diagnosis of Duchenne muscular dystrophy.
    Forrest SM; Smith TJ; Cross GS; Kenwrick SJ; England S; Flint T; Davies KE
    J R Coll Physicians Lond; 1988 Apr; 22(2):65-7. PubMed ID: 3294388
    [No Abstract]   [Full Text] [Related]  

  • 48. Upregulation of utrophin in the myocardium of a carrier of Duchenne muscular dystrophy.
    Behr TM; Fischer P; Mudra H; Theisen K; Spes C; Uberfuhr P; Müller-Felber W; Pongratz DE; Angermann C
    Eur Heart J; 1997 Apr; 18(4):699-700. PubMed ID: 9129907
    [No Abstract]   [Full Text] [Related]  

  • 49. Carrier status diagnosis in Duchenne muscular dystrophy with "conformational" DNA polymorphism.
    Zietkiewicz E; Simard LR; Melançon SB; Vanasse M; Labuda D
    Lancet; 1992 Jan; 339(8785):134. PubMed ID: 1345868
    [No Abstract]   [Full Text] [Related]  

  • 50. Detection of carriers of human Duchenne muscular dystrophy by freeze-fracture analysis of erythrocyte plasmalemmal intramembrane particles.
    Shivers RR; Martin K; Atkinson BG
    Am J Clin Pathol; 1986 Feb; 85(2):131-4. PubMed ID: 3946298
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Update on the molecular genetics of Duchenne muscular dystrophy.
    Siddique T; Bartlett R; Pericak-Vance M; Yamaoka L; Koh J; Chen J; Hung WY; Kandt R; Roses AD
    Aust Paediatr J; 1988; 24 Suppl 1():9-14. PubMed ID: 3060079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of RFLPs and DNA deletions in the Chinese Duchenne muscular dystrophy gene.
    Zeng YT; Chen MJ; Ren ZR; Qui XK; Huang SZ
    J Med Genet; 1991 Mar; 28(3):167-70. PubMed ID: 1675685
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy.
    Hodgson SV; Bobrow M
    Br Med Bull; 1989 Jul; 45(3):719-44. PubMed ID: 2688825
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carrier detection in Duchenne muscular dystrophy. Evidence from a study of obligatory carriers and mothers of isolated cases.
    Sibert JR; Harper PS; Thompson RJ; Newcombe RG
    Arch Dis Child; 1979 Jul; 54(7):534-7. PubMed ID: 485196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New mutations in Duchenne muscular dystrophy.
    Lane RJ; Partridge T; Rose FC
    Lancet; 1988 Oct; 2(8617):971-2. PubMed ID: 2902424
    [No Abstract]   [Full Text] [Related]  

  • 56. Carrier estimations in Duchenne muscular dystrophy families in Northern Ireland using RFLP analysis.
    Kelly ED; Graham CA; Hill AJ; Nevin NC
    J Med Genet; 1990 Feb; 27(2):101-4. PubMed ID: 1969486
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estimation of proportion of new mutants among cases of Duchenne muscular dystrophy.
    Davie AM; Emery AE
    J Med Genet; 1978 Oct; 15(5):339-45. PubMed ID: 739522
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Linkage analysis of polymorphisms within the DNA fragment XJ cloned from the breakpoint of an X;21 translocation associated with X linked muscular dystrophy.
    Thompson MW; Ray PN; Belfall B; Duff C; Logan C; Oss I; Worton RG
    J Med Genet; 1986 Dec; 23(6):548-55. PubMed ID: 2879926
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carrier diagnosis of Duchenne muscular dystrophy using restriction fragment length polymorphisms.
    Hejtmancik JF; Harris SG; Tsao CC; Ward PA; Caskey CT
    Neurology; 1986 Dec; 36(12):1553-62. PubMed ID: 2878392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic analysis of the Duchenne muscular dystrophy gene.
    Prior TW
    Arch Pathol Lab Med; 1991 Oct; 115(10):984-90. PubMed ID: 1898245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.